Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000633623 | SCV000716678 | likely benign | not provided | 2021-01-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002315903 | SCV000739001 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2017-02-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000633623 | SCV001157328 | likely benign | not provided | 2019-11-21 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002063018 | SCV002489230 | likely benign | Congenital contractural arachnodactyly | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000633623 | SCV004159323 | likely benign | not provided | 2023-06-01 | criteria provided, single submitter | clinical testing | FBN2: BP4, BP7 |